15:41 Dec 20
Remus Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Remus Pharmaceuticals Ltd.
Industry Pharmaceuticals
15:41 Dec 20
Quality
0/100
Not Eligible
Valuation
2/100
Expensive Valuation
Technical
51/100
Technically Neutral
Strength
3
Weakness
2
Opportunity
0
Threats
0
29.90 %
ROE %
10.09 %
ROA %
0.00
EPS
708.31
BVPS
12.22 %
Net Profit Margin
| Mar 2024 | ||
|---|---|---|
| Net Sales | 212.5 | |
| Operating Expenses + | 184.69 | |
| Raw Material | 164.99 | |
| Increase Decrease in Cost | -0.67 | |
| Other Manufacturing Expense | 0 | |
| Employee Cost | 7.42 | |
| Miscellaneous Expenses | 342.93 | |
| Operating Profit | 27.81 | |
| Other Income | 5.4 | |
| Depreciation | 0.9 | |
| Interest | 0.48 | |
| Profit before tax and exceptio.. | 31.83 | |
| Exceptional Items | 0 | |
| PBT | 31.83 | |
| Provision for Taxation | 5.85 | |
| Net Profit | 25.98 | |
| NET Profit after MI | 25.98 | |
| EPS | 152.01 | |
| Operating Profit Margin (%) | 13.09 | |
| Net Profit Margin (%) | 12.23 |
ShareHolding
Promoter
FII
Public
Mutual Funds
Other Institutions
All Data in Percentage (%)
| Sep 24 | Mar 24 | |
|---|---|---|
| Promoter | 70.80 | 70.60 |
| FII | 3.20 | 3.20 |
| MF | 0.00 | 0.00 |
| Public | 25.20 | 25.50 |
| Others | 0.10 | 0.00 |
| Others | 0.70 | 0.70 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
